Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors

Capital International buys 3% stake in Intas Pharmaceuticals for $107 million


According to two people familiar with the matter, Capital International Private Equity Fund has acquired about 3 percent of Intas Pharmaceuticals for $107 million from ChrysCapital, reported livemint.com.

One of the sources said the transaction values Intas Pharma at around $3.5 billion.

ChrysCapital, which had a 6-percent stake in Intas prior to the sale, will continue to own the remaining stake.

Source: firstwordpharma.com

Back to the list

Invite partners to the exhibition
Facebook Youtube RSS Feed

Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34